Late Night with LRIG
Michael Scholle, MS, MBA
VP of Operations and Technology
Samdi Tech, Inc
SAMDI Tech., Inc leads the industry in label-free, high-throughput assays for drug discovery. Here, we will present our novel approaches to apply SAMDI towards small molecule biochemical and biophysical assays. SAMDI combines Self-Assembled-Monolayers on high-density biochip arrays and matrix assisted laser desorption ionization (MALDI) mass spectrometry that enables rapid and quantitative assays capable of screening millions of compounds per day. The SAMDI assay opens avenues for better, faster, label-free screens for a broad range of biochemical activities.
VP of Operations and Technology
Samdi Tech, Inc
PhD in chemistry (University of Chicago), Postdoc in Molecular biology, chromatin biology, epigenetics (Institut Curie, Paris France).
SAMDI Tech, Inc. - Novel approaches to small molecule assays using SAMDI mass spectrometry
Monday, February 5
6:00 PM – 6:40 PM
The asset you are trying to access is locked. Please enter your access key to unlock.